Fortitude Mines 33,646 ZEC in Q2 to Advance Business Combination with HeartSciences
Fortitude delivered $20.9 million in Q2 revenue and $8.5 million in adjusted EBITDA, highlighting operational efficiency as it coordinates a merger with medical technology company HeartSciences.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day